We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

34 hedge funds and large institutions have $104M invested in Ocular Therapeutix in 2014 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SHI
SV Health Investors
Massachusetts
+$38.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$19M
3
Capital Research Global Investors
Capital Research Global Investors
California
+$13.6M
4
RIM
RS Investment Management
California
+$9.03M
5
PCM
Pentwater Capital Management
Florida
+$7.25M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SHI
1
SV Health Investors
Massachusetts
$38.7M +$38.2M +2,585,607 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$19.3M +$19M +1,287,610 New
Capital Research Global Investors
3
Capital Research Global Investors
California
$13.8M +$13.6M +921,000 New
RIM
4
RS Investment Management
California
$9.14M +$9.03M +610,900 New
PCM
5
Pentwater Capital Management
Florida
$7.33M +$7.25M +490,000 New
Federated Hermes
6
Federated Hermes
Pennsylvania
$5.24M +$5.18M +350,000 New
BFA
7
BlackRock Fund Advisors
California
$2.12M +$2.09M +141,562 New
Deutsche Bank
8
Deutsche Bank
Germany
$1.5M +$1.48M +100,002 New
BIT
9
BlackRock Institutional Trust
California
$1.2M +$1.19M +80,383 New
Morgan Stanley
10
Morgan Stanley
New York
$992K +$979K +66,184 New
State Street
11
State Street
Massachusetts
$596K +$590K +39,900 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$588K +$581K +39,322 New
SIM
13
Spark Investment Management
New York
$575K +$572K +38,700 New
USAA
14
United Services Automobile Association
Texas
$476K +$470K +31,800 New
Millennium Management
15
Millennium Management
New York
$323K +$319K +21,559 New
BIM
16
BlackRock Investment Management
Delaware
$232K +$229K +15,514 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$229K +$226K +15,306 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$205K +$202K +13,684 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$195K +$192K +12,979 New
Northern Trust
20
Northern Trust
Illinois
$168K +$166K +11,223 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$159K +$157K +10,600 New
TCIM
22
TIAA CREF Investment Management
New York
$158K +$156K +10,539 New
BG
23
BlackRock Group
United Kingdom
$82K +$81.1K +5,487 New
TA
24
Teachers Advisors
New York
$80K +$79.2K +5,359 New
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$55K +$54K +3,650 New
1
2

OCUL Hedge Fund Activity: Q3 2014 in Review

34 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2014, worth a combined $104M.

Buyers outnumbered sellers: 34 funds opened new OCUL positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SV Health Investors, opening a new position worth an estimated $38.2M.

  • 34 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $104M of Ocular Therapeutix stock for Q3 2014.
  • 34 funds opened new Ocular Therapeutix positions in Q3 2014 and 0 closed out, a net change of +34 holders.
  • The largest Ocular Therapeutix buyer in Q3 2014 was SV Health Investors, an estimated $38.2M added.

Based on aggregated 13F filings for Q3 2014.